المؤلفون: Basu HS; Department of Genitourinary Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Wilganowski N; Department of Genitourinary Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Robertson S; Department of Genitourinary Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Reuben JM; Department of Hematopathology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Cohen EN; Department of Hematopathology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Zurita A; Department of Genitourinary Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Ramachandran S; Department of Genitourinary Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Xiao LC; Department of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Titus M; Department of Genitourinary Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA., Wilding G; Department of Genitourinary Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.

المصدر: The Prostate [Prostate] 2021 Sep; Vol. 81 (12), pp. 799-811. Date of Electronic Publication: 2021 Jun 25.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*pharmacology , Antineoplastic Agents/*pharmacology , Benzamides/*pharmacology , Glycolysis/*physiology , Mitochondria/*metabolism , Nitriles/*pharmacology , Phenylthiohydantoin/*pharmacology , Prostatic Neoplasms, Castration-Resistant/*metabolism, Androgen Antagonists/therapeutic use ; Antineoplastic Agents/therapeutic use ; Benzamides/therapeutic use ; Benzeneacetamides/pharmacology ; Benzeneacetamides/therapeutic use ; Cell Line, Tumor ; Cell Survival/drug effects ; Cell Survival/physiology ; Glycolysis/drug effects ; Humans ; Male ; Mitochondria/drug effects ; Nitriles/therapeutic use ; Phenylthiohydantoin/therapeutic use ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Thiadiazoles/pharmacology ; Thiadiazoles/therapeutic use

المؤلفون: DiPaola RS; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Electronic address: Robert.DiPaola@rutgers.edu., Chen YH; Dana-Farber Cancer Institute, Boston, MA, USA., Bubley GJ; Beth Israel Deaconess Medical Center, Boston, MA, USA., Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Hahn NM; Indiana University Simon Cancer Center, Indianapolis, IN, USA., Carducci MA; Johns Hopkins University, Baltimore, MD, USA., Lattime EC; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Gulley JL; National Cancer Institute, Bethesda, MD, USA., Arlen PM; National Cancer Institute, Bethesda, MD, USA., Butterfield LH; University of Pittsburgh, Pittsburgh, PA, USA., Wilding G; UW Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.

المصدر: European urology [Eur Urol] 2015 Sep; Vol. 68 (3), pp. 365-71. Date of Electronic Publication: 2014 Dec 18.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*therapeutic use , Cancer Vaccines/*therapeutic use , Kallikreins/*immunology , Prostate-Specific Antigen/*immunology , Prostatic Neoplasms/*drug therapy, Aged ; Cancer Vaccines/immunology ; Combined Modality Therapy ; Disease Progression ; Fowlpox virus/immunology ; Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use ; Humans ; Kallikreins/blood ; Male ; Middle Aged ; Prostate-Specific Antigen/blood ; Prostatectomy ; Vaccinia virus/immunology

المؤلفون: Hussain M; University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI 48109-0946, USA. mahahuss@umich.edu, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr

المصدر: The New England journal of medicine [N Engl J Med] 2013 Apr 04; Vol. 368 (14), pp. 1314-25.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Androgen Antagonists/*administration & dosage , Anilides/*administration & dosage , Gonadotropin-Releasing Hormone/*analogs & derivatives , Goserelin/*administration & dosage , Nitriles/*administration & dosage , Prostatic Neoplasms/*drug therapy , Tosyl Compounds/*administration & dosage, Aged ; Anilides/adverse effects ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Hormonal/adverse effects ; Confidence Intervals ; Drug Administration Schedule ; Follow-Up Studies ; Gonadotropin-Releasing Hormone/therapeutic use ; Goserelin/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis/drug therapy ; Nitriles/adverse effects ; Penile Erection/drug effects ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Survival Analysis ; Tosyl Compounds/adverse effects

المؤلفون: McNeel DG; University of Wisconsin Carbone Cancer Center, Madison, 53792, USA. dm3@medicine.wisc.edu, Smith HA, Eickhoff JC, Lang JM, Staab MJ, Wilding G, Liu G

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2012 Jul; Vol. 61 (7), pp. 1137-47. Date of Electronic Publication: 2011 Dec 31.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*administration & dosage , Anilides/*administration & dosage , Antibodies, Monoclonal/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Nitriles/*administration & dosage , Prostate-Specific Antigen/*blood , Prostatic Neoplasms/*drug therapy , Tosyl Compounds/*administration & dosage, Aged ; Anilides/adverse effects ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Disease Progression ; Dose-Response Relationship, Drug ; Humans ; Male ; Middle Aged ; Nitriles/adverse effects ; Prostate-Specific Antigen/immunology ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Tosyl Compounds/adverse effects ; Treatment Outcome

المؤلفون: Rathkopf D; Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA., Liu G, Carducci MA, Eisenberger MA, Anand A, Morris MJ, Slovin SF, Sasaki Y, Takahashi S, Ozono S, Fung NK, Cheng S, Gan J, Gottardis M, Obermeier MT, Reddy J, Zhang S, Vakkalagadda BJ, Alland L, Wilding G, Scher HI

مؤلفون مشاركون: Prostate Cancer Clinical Trials Consortium

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2011 Feb 15; Vol. 17 (4), pp. 880-7. Date of Electronic Publication: 2010 Dec 03.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*administration & dosage , Bone Neoplasms/*secondary , Bridged Bicyclo Compounds, Heterocyclic/*administration & dosage , Imides/*administration & dosage , Prostatic Neoplasms/*drug therapy, Aged ; Aged, 80 and over ; Androgen Antagonists/adverse effects ; Androgen Antagonists/pharmacokinetics ; Bone Neoplasms/pathology ; Bridged Bicyclo Compounds, Heterocyclic/adverse effects ; Bridged Bicyclo Compounds, Heterocyclic/pharmacokinetics ; Humans ; Imides/adverse effects ; Imides/pharmacokinetics ; Male ; Middle Aged ; Orchiectomy ; Prostate-Specific Antigen/metabolism ; Prostatic Neoplasms/pathology ; Treatment Outcome

المؤلفون: Lardy H; Department of Biochemistry, Institute for Enzyme Research, University of Wisconsin, Madison 53726, United States. halardy@wisc.edu, Marwah A, Zhong W, Moore R, Marwah P, Thompson T, Wilding G

المصدر: The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2008 Jul; Vol. 111 (1-2), pp. 60-5. Date of Electronic Publication: 2008 May 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Country of Publication: England NLM ID: 9015483 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0960-0760 (Print) Linking ISSN: 09600760 NLM ISO Abbreviation: J Steroid Biochem Mol Biol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Tolerance*, Androgen Antagonists/*metabolism , Androgen Antagonists/*pharmacology , Androstadienes/*metabolism , Androstadienes/*pharmacology, Androgen Antagonists/chemistry ; Androgen Antagonists/isolation & purification ; Androstadienes/chemistry ; Androstadienes/isolation & purification ; Animals ; Male ; Molecular Structure ; Random Allocation ; Rats ; Rats, Sprague-Dawley

المؤلفون: Hussain M; University of Michigan, Ann Arbor, MI, USA., Tangen CM, Higano C, Schelhammer PF, Faulkner J, Crawford ED, Wilding G, Akdas A, Small EJ, Donnelly B, MacVicar G, Raghavan D

مؤلفون مشاركون: Southwest Oncology Group Trial 9346 (INT-0162)

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2006 Aug 20; Vol. 24 (24), pp. 3984-90.

نوع المنشور: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*therapeutic use , Antineoplastic Agents, Hormonal/*therapeutic use , Biomarkers, Tumor/*blood , Prostate-Specific Antigen/*blood , Prostatic Neoplasms/*drug therapy , Prostatic Neoplasms/*immunology, Adult ; Aged ; Aged, 80 and over ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Predictive Value of Tests ; Proportional Hazards Models ; Prospective Studies ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Risk Factors ; Survival Analysis ; Time Factors

المؤلفون: Messing EM; Department of Urology, University of Rochester School of Medicine, Rochester, NY 14642, USA. edward_messing@urmc.rochester.edu, Manola J, Yao J, Kiernan M, Crawford D, Wilding G, di'SantAgnese PA, Trump D

مؤلفون مشاركون: Eastern Cooperative Oncology Group study EST 3886

المصدر: The Lancet. Oncology [Lancet Oncol] 2006 Jun; Vol. 7 (6), pp. 472-9.

نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Print ISSN: 1470-2045 (Print) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymph Node Excision* , Prostatectomy*, Androgen Antagonists/*therapeutic use , Antineoplastic Agents, Hormonal/*therapeutic use , Neoplasm Recurrence, Local/*prevention & control , Prostatic Neoplasms/*drug therapy, Aged ; Androgen Antagonists/administration & dosage ; Antineoplastic Agents, Hormonal/administration & dosage ; Combined Modality Therapy ; Disease-Free Survival ; Drug Administration Schedule ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Multicenter Studies as Topic ; Neoplasm Staging ; Pelvis ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Randomized Controlled Trials as Topic

المؤلفون: Thompson TA; University of Wisconsin Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin 53792, USA., Wilding G

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2003 Aug; Vol. 2 (8), pp. 797-803.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Print ISSN: 1535-7163 (Print) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*therapeutic use , Antioxidants/*therapeutic use , Chromans/*therapeutic use , Prostatic Neoplasms/*drug therapy , Vitamin E/*therapeutic use, Humans ; Male ; Prostate-Specific Antigen ; Tumor Cells, Cultured

المؤلفون: Lee YF; George Whipple Laboratory for Cancer Research, Department of Pathology, and The Cancer Center, University of Rochester Medical Center, New York 14642, USA., Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C

المصدر: Cancer research [Cancer Res] 2002 Nov 01; Vol. 62 (21), pp. 6039-44.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*pharmacology , Flutamide/*analogs & derivatives , Flutamide/*pharmacology , MAP Kinase Signaling System/*drug effects , Mitogen-Activated Protein Kinases/*metabolism , Prostatic Neoplasms/*enzymology , Receptors, Androgen/*physiology, Cell Division/drug effects ; Cell Division/physiology ; Cyclin D1/biosynthesis ; Enzyme Activation ; ErbB Receptors/antagonists & inhibitors ; Flutamide/antagonists & inhibitors ; Humans ; MAP Kinase Signaling System/physiology ; Male ; Mitogen-Activated Protein Kinase 1/metabolism ; Mitogen-Activated Protein Kinase 3 ; Neoplasms, Hormone-Dependent/enzymology ; Neoplasms, Hormone-Dependent/pathology ; Phosphorylation ; Prostatic Neoplasms/pathology ; Proto-Oncogene Proteins c-raf/metabolism ; Quinazolines ; Substance Withdrawal Syndrome/enzymology ; Substance Withdrawal Syndrome/etiology ; Tyrphostins/pharmacology ; ras Proteins/metabolism